Therapeutic Asset Ratings

230 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Personalized Neoantigen Peptide Vaccine Solid Tumor, Adult	Seqker Biosciences, Inc.	P1/2	CC (44)
Polyiclc Solid Tumor, Adult	Seqker Biosciences, Inc.	P1/2	CC (44)
Proleukin Solid Tumor, Adult	ImCheck Therapeutics	P1/2	CC (44)
THIOGUANINE ANHYDROUS Solid Tumor, Adult	Kristoffer Rohrberg	P1/2	CC (44)
Durvalumab Solid Tumor, Adult	University of California, Irvine	P1	CC (42)
64cu-grip b Solid Tumor, Adult	Rahul Aggarwal	P1/2	CC (41)
a2b395 Solid Tumor, Adult	A2 Biotherapeutics Inc.	P1/2	CC (41)
a2b530 Solid Tumor, Adult	A2 Biotherapeutics Inc.	P1/2	CC (41)
a2b543 Solid Tumor, Adult	A2 Biotherapeutics Inc.	P1/2	CC (41)
a2b694 Solid Tumor, Adult	A2 Biotherapeutics Inc.	P1/2	CC (41)
abo2011 Solid Tumor, Adult	Suzhou Abogen Biosciences Co., Ltd.	P1/2	CC (41)
Ace-86225106 Solid Tumor, Adult	Acerand Therapeutics (Shanghai) Limited	P1/2	CC (41)
ad1208 Solid Tumor, Adult	Avelos Therapeutics Inc.	P1/2	CC (41)
ak119 Solid Tumor, Adult	Akeso	P1/2	CC (41)
ANTI-CD32B MONOCLONAL ANTIBODY BI-1206 Solid Tumor, Adult	BioInvent International AB	P1/2	CC (41)
Apg-2575 Solid Tumor, Adult	Ascentage Pharma Group Inc.	P1/2	CC (41)
Aspartate zinc Solid Tumor, Adult	Vector Vitale LLC	P1/2	CC (41)
Attr-01 Solid Tumor, Adult	Accession Therapeutics Limited	P1/2	CC (41)
Catequentinib Solid Tumor, Adult	Sarcoma Oncology Research Center, LLC	P1/2	CC (41)
cd70-targeting car-t cells Solid Tumor, Adult	Chinese PLA General Hospital	P1/2	CC (41)
Crb-701 Solid Tumor, Adult	Corbus Pharmaceuticals Inc.	P1/2	CC (41)
ct3001 Solid Tumor, Adult	Crossignal Therapeutics, Inc.	P1/2	CC (41)
Dasatinib Solid Tumor, Adult	Medical University of South Carolina	P1/2	CC (41)
db-1419 Solid Tumor, Adult	DualityBio Inc.	P1/2	CC (41)
Decoy20 Solid Tumor, Adult	Indaptus Therapeutics, Inc	P1/2	CC (41)

Showing 51 to 75 of 230 assets

PreviousPage 3 of 10Next